Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DP-R212 Pharmacokinetic Study Pharmacokinetic Characteristics of DP-R212 in Comparison to Each Component Coadministered in Healthy Volunteers

NCT02814500 is registered in ClinicalTrials.gov with Alvogen Korea as lead sponsor.

NCT NCT02814500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02814500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DP-R212 Pharmacokinetic Study Pharmacokinetic Characteristics of DP-R212 in Comparison to Each Component Coadministered in Healthy Volunteers
Lead sponsor
Alvogen Korea
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2016
Completion date
September 30, 2016
Enrollment
36 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy